NCT03682783

Artificial Intelligence-assisted Glaucoma Screening (AIAGS)

The Development of Artificial Intelligence-assisted Glaucoma Screening Program

• Status: Unknown
• Phase: —
• Study type: Observational
• Enrollment: 8,000 (estimated)
• Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine · Academic / Other
• Sex: All
• Age: —
• Healthy volunteers: Accepted

Summary

This study will develop an artificial intelligence (AI) program for the screening of glaucoma.

Detailed description

We have realized that the glaucomatous optic neuropathy is irreversible. But if early detection and early intervention can be performed to control the development of the disease, it can greatly reduce the blindness rate of glaucoma, improve the life quality and physiological and mental health of patients, and alleviate the social burden. Therefore, screening and early diagnosis of glaucoma is the focus of glaucoma prevention. China has a population of 1.3 billion, which greatly increase the difficulty of disease screening. In recent years, the intersection of artificial intelligence (AI) technology and modern medicine has made efficient and rapid disease screening possible.

Conditions

• Glaucoma Eye

Interventions

Type	Name	Description
DIAGNOSTIC_TEST	Fundus Image	Fundus image of optic nerve

Timeline

• Start date: 2018-10-01
• Primary completion: 2020-10-01
• Completion: 2021-10-30
• First posted: 2018-09-25
• Last updated: 2018-09-25

Locations

1 site across 1 country: China